Cas 5250-15-7,(E)-1-(4-bromo-2-hydroxyphenyl)-3-(pyridin-2-yl)prop-2-en-1-one

5250-15-7

Post Buying Request

Basic information

Product Name: (E)-1-(4-bromo-2-hydroxyphenyl)-3-(pyridin-2-yl)prop-2-en-1-one
Synonyms: (E)-1-(4-bromo-2-hydroxyphenyl)-3-(pyridin-2-yl)prop-2-en-1-one
CAS NO:5250-15-7
Molecular Formula:
Molecular Weight: 304.143
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (E)-1-(4-bromo-2-hydroxyphenyl)-3-(pyridin-2-yl)prop-2-en-1-one(CAS DataBase Reference)
NIST Chemistry Reference: (E)-1-(4-bromo-2-hydroxyphenyl)-3-(pyridin-2-yl)prop-2-en-1-one(5250-15-7)
EPA Substance Registry System: (E)-1-(4-bromo-2-hydroxyphenyl)-3-(pyridin-2-yl)prop-2-en-1-one(5250-15-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 5250-15-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

5250-15-7 Suppliers

Recommended suppliers

5250-15-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 5250-15-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,2,5 and 0 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 5250-15:
(6*5)+(5*2)+(4*5)+(3*0)+(2*1)+(1*5)=67
67 % 10 = 7
So 5250-15-7 is a valid CAS Registry Number.

5250-15-7Upstream product

5250-15-7Downstream Products

5250-15-7Relevant academic research and scientific papers

BENZENE-FUSED 6-MEMBERED OXYGEN-CONTAINING HETEROCYCLIC DERIVATIVES OF BICYCLIC HETEROARYLS

-

Page/Page column 90, (2011/06/23)

The invention relates to new derivatives of formula I, wherein the substituents are as defined in the specification; to processes for the preparation of such derivatives; pharmaceutical compositions comprising such derivatives; such derivatives as a medicament; such derivatives for the treatment of a proliferative disease.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 5250-15-7